Tremfya 100 MG/ML one-pressml
Ended Awarded Last action
- Contract number
- SPE2DR26F9LK1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,292
Award facts
- Contract value 100% obligated
- $15,291.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,291.86 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of TREMFYA 100 mg/ml (guselkumab), a prescription medication used to treat plaque psoriasis and other inflammatory skin conditions. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of January 16, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor providing critical medical commodities to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and military treatment facilities. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products across multiple therapeutic domains through competitively awarded delivery orders with firm fixed pricing, making it a key vendor for military and veteran healthcare supply chains.
Quick answers
Who was awarded contract SPE2DR26F9LK1?
SPE2DR26F9LK1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LK1 worth?
The government has obligated $15,292 on SPE2DR26F9LK1.
Is contract SPE2DR26F9LK1 an order under another contract?
Yes. SPE2DR26F9LK1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LK1 competed?
The extent of competition for SPE2DR26F9LK1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award